1. Home
  2. Labeler Index
  3. Janssen Pharmaceuticals, Inc
  4. 50458-609
  5. NDC Package Code: 50458-609-01 Invega Trinza

NDC Package 50458-609-01 Invega Trinza

Paliperidone Palmitate Injection, Suspension, Extended Release Intramuscular - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. NDC HCPCS Crosswalk
    3. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
50458-609-01
Package Description:
1 SYRINGE in 1 KIT / 1 mL in 1 SYRINGE
Product Code:
50458-609
Proprietary Name:
Invega Trinza
Non-Proprietary Name:
Paliperidone Palmitate
Substance Name:
Paliperidone Palmitate
Usage Information:
Paliperidone is used to treat a certain mental/mood disorder called schizophrenia. This medication can decrease hallucinations, help you to think more clearly and positively about yourself, feel less agitated, and take a more active part in everyday life. Paliperidone is an antipsychotic drug (atypical type). It works by helping to restore the balance of certain natural substances (neurotransmitters) in the brain. This long-acting form of paliperidone is used only after you have received treatment with the form that is injected once a month for at least 4 months.
11-Digit NDC Billing Format:
50458060901
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
  • RxCUI: 1650966 - paliperidone palmitate 273 MG in 0.88 ML Prefilled Syringe
  • RxCUI: 1650966 - 0.88 ML paliperidone palmitate 310 MG/ML Prefilled Syringe
  • RxCUI: 1650966 - paliperidone palmitate 273 MG per 0.88 ML Prefilled Syringe
  • RxCUI: 1650968 - Invega Trinza 273 MG in 0.88 ML Prefilled Syringe
  • RxCUI: 1650968 - 0.88 ML paliperidone palmitate 310 MG/ML Prefilled Syringe [Invega]
Product Type:
Human Prescription Drug
Labeler Name:
Janssen Pharmaceuticals, Inc
Dosage Form:
Injection, Suspension, Extended Release - A sterile preparation intended for parenteral use which has been formulated in a manner to allow at least a reduction in dosing frequency as compared to that drug presented as a conventional dosage form (e.g., as a solution or a prompt drug-releasing, conventional solid dosage form).
Administration Route(s):
Intramuscular - Administration within a muscle.
Active Ingredient(s):
PALIPERIDONE PALMITATE 819 mg/2.63mL
Pharmacologic Class(es):
Atypical Antipsychotic - [EPC] (Established Pharmacologic Class)
Sample Package:
No
FDA Application Number:
NDA207946
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
05-19-2015
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

NDC HCPCS Crosswalk

This crosswalk is intended to help the public understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes.

NDC 50458-609-01 HCPCS crosswalk information with package details and bill units information.

NDC Billing CodeHCPCS CodeHCPCS Code Desc.DosagePackage SizePackage QuantityBillable UnitsBillable Units / Pkg
50458060901J2427Inj, invega hafyera/trinza1MG2.6251819819

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 50458-609-01?

The NDC Packaged Code 50458-609-01 is assigned to a package of 1 syringe in 1 kit / 1 ml in 1 syringe of Invega Trinza, a human prescription drug labeled by Janssen Pharmaceuticals, Inc. The product's dosage form is injection, suspension, extended release and is administered via intramuscular form.

Is NDC 50458-609 included in the NDC Directory?

Yes, Invega Trinza with product code 50458-609 is active and included in the NDC Directory. The product was first marketed by Janssen Pharmaceuticals, Inc on May 19, 2015 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 50458-609-01?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 50458-609-01?

The 11-digit format is 50458060901. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-250458-609-015-4-250458-0609-01